Medical Technology

@techcrunch.com 2 years ago

How Colossal sold investors on a quest to resurrect a woolly mammoth

@xconomy.com 4 years ago

Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal

@xconomy.com 4 years ago

Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits

@xconomy.com 5 years ago

In Landmark Gene-Editing Study, Sangamo Reports Little Benefit

@xconomy.com 5 years ago

Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial

@xconomy.com 6 years ago

Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M

@techcrunch.com 6 years ago

With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas